NRX Pharmaceuticals Inc (NRXP)
3.85
-0.05
(-1.28%)
USD |
NASDAQ |
May 23, 10:26
NRX Pharmaceuticals 1 Year Total Returns (Daily): -43.07% for May 22, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 22, 2024 | -43.07% |
May 21, 2024 | -46.39% |
May 20, 2024 | -43.61% |
May 17, 2024 | -47.93% |
May 16, 2024 | -45.50% |
May 15, 2024 | -53.63% |
May 14, 2024 | -49.52% |
May 13, 2024 | -52.54% |
May 10, 2024 | -51.36% |
May 09, 2024 | -52.74% |
May 08, 2024 | -54.52% |
May 07, 2024 | -54.05% |
May 06, 2024 | -49.96% |
May 03, 2024 | -64.79% |
May 02, 2024 | -68.06% |
May 01, 2024 | -61.83% |
April 30, 2024 | -55.61% |
April 29, 2024 | -38.92% |
April 26, 2024 | -40.10% |
April 25, 2024 | -48.85% |
April 24, 2024 | -46.51% |
April 23, 2024 | -49.17% |
April 22, 2024 | -50.00% |
April 19, 2024 | -52.13% |
April 18, 2024 | -52.06% |
Date | Value |
---|---|
April 17, 2024 | -34.67% |
April 16, 2024 | -30.48% |
April 15, 2024 | -20.78% |
April 12, 2024 | -17.42% |
April 11, 2024 | -11.29% |
April 10, 2024 | -2.98% |
April 09, 2024 | -10.88% |
April 08, 2024 | -5.35% |
April 05, 2024 | -3.64% |
April 04, 2024 | -10.17% |
April 03, 2024 | -23.84% |
April 02, 2024 | -24.14% |
April 01, 2024 | -20.35% |
March 28, 2024 | -34.91% |
March 27, 2024 | -27.12% |
March 26, 2024 | -29.31% |
March 25, 2024 | -27.39% |
March 22, 2024 | -22.22% |
March 21, 2024 | -25.72% |
March 20, 2024 | -30.71% |
March 19, 2024 | -32.22% |
March 18, 2024 | -27.42% |
March 15, 2024 | -33.07% |
March 14, 2024 | -38.62% |
March 13, 2024 | -30.18% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-97.84%
Minimum
Jul 25 2022
486.6%
Maximum
Feb 02 2021
-12.66%
Average
-13.61%
Median
Sep 30 2021
1 Year Total Returns (Daily) Benchmarks
Cyclacel Pharmaceuticals Inc | -77.76% |
Achieve Life Sciences Inc | -36.81% |
EyePoint Pharmaceuticals Inc | 66.47% |
Nanoviricides Inc | 99.12% |
GlycoMimetics Inc | -86.43% |